![Julien Alberici](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julien Alberici
Algemeen Directeur bij
Mathym SAS
Profiel
Julien Alberici is the founder.
Founded Mathym SAS in 2013 as Chief Executive Officer.
Current job at Octalfa SAS since 2013 as CEO.
Current job at ORPHELIA Pharma SAS as Director.
Former job at Baikowski SA as Director-Business Development.
Actieve functies van Julien Alberici
| Bedrijven | Functie | Begin |
|---|---|---|
Octalfa SAS
 Octalfa SAS Investment ManagersFinance Octalfa is a hands-on investor who plays an active role in their portfolio companies and seeks board representation. The firm focuses on early-stage businesses including seed-stage projects in the life sciences sectors, and may also co-invest in later-stage companies. Octalfa invests from their own balance sheet, in the EUR 500 thousand to 1.5 million range, as a one-time investor or over several financing rounds. | Hoofd Administratief Officier | 01-01-2013 |
Mathym SAS
 Mathym SAS Miscellaneous Commercial ServicesCommercial Services Manufacutures and developps innovative colloïdal solutions. | Algemeen Directeur | 01-09-2013 |
ORPHELIA Pharma SAS
 ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology Specializes on biopharmaceutical products improving the health and well being of severely disabled children | Directeur/Bestuurslid | - |
Eerdere bekende functies van Julien Alberici
| Bedrijven | Functie | Einde |
|---|---|---|
| BAIKOWSKI | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Octalfa SAS
Octalfa SAS Investment ManagersFinance Octalfa is a hands-on investor who plays an active role in their portfolio companies and seeks board representation. The firm focuses on early-stage businesses including seed-stage projects in the life sciences sectors, and may also co-invest in later-stage companies. Octalfa invests from their own balance sheet, in the EUR 500 thousand to 1.5 million range, as a one-time investor or over several financing rounds. | Finance |
Mathym SAS
Mathym SAS Miscellaneous Commercial ServicesCommercial Services Manufacutures and developps innovative colloïdal solutions. | Commercial Services |
Baikowski SA
 Baikowski SA Chemicals: SpecialtyProcess Industries Produces and supplies alumina powders, phosphors & formulations | Process Industries |
ORPHELIA Pharma SAS
ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology Specializes on biopharmaceutical products improving the health and well being of severely disabled children | Health Technology |
